Studies using animal models of ETBF-associated carcinogenesis have revealed that BFT exacerbates tumor development by promoting the production of pro-inflammatory cytokines, including interleukin-17A (IL-17A) and CXCL1, in the MinApc+/− mouse model [20,21,22]. The gene discussed is IL17A; the disease is neoplasm.